Peripheral neuropathy, a complex and multifaceted disorder, presents a diagnostic challenge in clinical practice due to its myriad etiologies and presentations. A comprehensive approach to evaluation and diagnosis is essential to ensure optimal patient outcomes.
Peripheral neuropathy may arise from systemic illnesses, infections, toxins, or genetic disorders. A thorough patient history and physical examination, including a detailed neurological examination, are the first steps in identifying potential causes. Laboratory investigations should be guided by the findings of the history and examination, focusing on ruling out common causes such as diabetes, vitamin deficiencies, and renal or liver diseases.
Electrodiagnostic studies, including nerve conduction studies and electromyography, are essential tools in the diagnosis of peripheral neuropathy. These tests help in determining the extent of nerve damage, the type of neuropathy (axonal or demyelinating), and the distribution (mononeuropathy or polyneuropathy).
Quantitative sensory testing, autonomic testing, and skin biopsies can provide further diagnostic insights. They can help distinguish between small and large fiber neuropathies, assess the severity of neuropathic pain, and detect autonomic involvement.
For patients with a family history suggestive of hereditary neuropathy or those with no identifiable cause after initial evaluation, genetic testing can be considered. It can identify pathogenic variants associated with hereditary neuropathies, providing definitive diagnosis and guiding management.
Diagnosing peripheral neuropathy requires a comprehensive approach that includes a thorough history, physical examination, appropriate laboratory investigations, neurophysiological testing, and, in some cases, genetic testing. This approach enables accurate diagnosis, guides treatment, and improves patient outcomes.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation